I risultati dello studio VERTIS CV.

The effect of serum total testosterone and other laboratory parameters on the prognosis of COVID-19.

Nel primo studio di fase 3 che include un gruppo di controllo trattato con placebo sono state valutate efficacia e sicurezza di osilodrostat.

Results suggest that patients with lichen planus should be screened for metabolic disorders.

Treatment shows a positive benefit-risk consideration for most patients.

Risultati dell’analisi post hoc di EMPA-REG OUTCOME.

L’uso di questi farmaci nei tumori endocrini è ancora oggetto di dibattito. Una revisione sistematica fa il punto su efficacia, sicurezza e rischio di recidiva

Aldosteronism can be the culprit.

Found in 19% of Chinese patients.

Hypothyroidism, celiac disease, and hyperthyroidism are the most common.

Favorable hormonal effects also seen.

Metformin improved some metabolic parameters and clinical outcomes.

Report elicits great interest from clinicians, endocrinologists and toxicologists.

The restrictions are being introduced after a safety review found that high-dose cyproterone medicines may increase risk for meningioma.